These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6874180)

  • 1. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women.
    Huisveld IA; Hospers JE; Bernink MJ; Erich WB; Bouma BN
    Int J Sports Med; 1983 May; 4(2):97-103. PubMed ID: 6874180
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives.
    Gordon EM; Ratnoff OD; Saito H; Donaldson VH; Pensky J; Jones PK
    J Lab Clin Med; 1980 Nov; 96(5):762-9. PubMed ID: 7419960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels.
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Seifried E; Lindhoff-Last E
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):524-34. PubMed ID: 19620844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of modern low-dose oral contraceptives on hemostasis.
    Daume E
    Adv Contracept; 1990 Dec; 6 Suppl():51-67; discussion 68. PubMed ID: 2149806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation changes during massive hepatic necrosis due to Amanita phalloides poisoning with special reference to antihemophilic globulin.
    Meili EO; Frick PG; Straub PW
    Helv Med Acta; 1970 Oct; 35(4):304-13. PubMed ID: 5507041
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood clotting, plasma kinins and fibrinolysis.
    Gjonnaess H; Stormorken H
    Thromb Diath Haemorrh; 1970 Oct; 24(1):308-10. PubMed ID: 5483971
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and fibrinolysis among female cyclists before and after exercise.
    Huisveld IA; Hospers AJ; Bernink MJ; Biersteker MW; Erich WB; Bouma BN
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Aug; 53(2):330-4. PubMed ID: 7118654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 17. Tests of hemostasis in swine: normal values and values in pigs affected with von Willebrand's disease.
    Bowie EJ; Owen CA; Zollman PE; Thompson JH; Fass DN
    Am J Vet Res; 1973 Nov; 34(11):1405-7. PubMed ID: 4542959
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
    Gordon EM; Ratnoff OD; Jones PK
    J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of procoagulants produced in cell cultures by tests of coagulation.
    Zacharski LR; McIntyre OR
    Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962
    [No Abstract]   [Full Text] [Related]  

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.